article thumbnail

Cooperation between Daimler and Renault-Nissan Alliance deepening in 2016

Green Car Congress

Launched in 2014, the smart two-seater is built at Daimler’s Hambach plant, France, whereas both four-seater vehicles are produced at Renault’s plant in Novo Mesto, Slovenia. Construction will be completed in 2017, followed by preparation for pilot production of Infiniti vehicles.

2016 218
article thumbnail

Renault-Nissan Alliance and Daimler partnership solid and expanding; 12 projects on three continents

Green Car Congress

The global scale of our projects ensures that this collaboration will continue to grow, and we expect to remain partners for the long run. The smart fortwo is being built at smart’s Hambach plant in France, while the Twingo and the smart forfour are being produced at Renault’s plant in Novo Mesto, Slovenia.

Nissan 210
article thumbnail

Renault-Nissan Alliance and Daimler expand cooperation with new $1.4B plant in Mexico; next-gen compacts for Mercedes-Benz and Infiniti

Green Car Congress

Start of production is planned for 2017 with Infiniti models. It also shows how our collaboration, which began in Europe, has become global in scope. The new plant will be built in the immediate vicinity of an already existing Nissan plant and will have an annual capacity of 300,000 vehicles when fully ramped up.

Infinity 210
article thumbnail

Euro car market has best H1 of century; diesels down 17%; AFVs up 31% for 5.4% of total; SUVs booming

Green Car Congress

on H1 2017, the growth recorded in Germany, France and Spain allowed the overall market to keep growing. —Felipe Munoz, JATO’s global analyst. Diesel’s biggest declines took place in Norway (-32%), the UK (-30%), Slovenia (-28%), Finland (-20%) and Belgium (-20%).

SUV 236
article thumbnail

A Smart Artificial Pancreas Could Conquer Diabetes

Cars That Think

The global frenzy of rapid prototyping and testing bore fruit: The first outpatient studies took place from September 2011 through January 2012 at camps for diabetic children in Israel, Germany, and Slovenia, where children with type 1 diabetes were monitored overnight using a laptop-based artificial pancreas system.

Personal 143